Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure
Gemcitabine is an intravenously administered nucleoside analog chemotherapeutic agent. The ability to deliver this agent as an oral drug would allow greater flexibility of administration and patient convenience; however, attempts have been fraught with high first-pass metabolism and potential intest...
Main Authors: | Shannon Dow, Richard Burton, Richard Smith, Jingqi Bao, Enaksha Wickremsinhe, Everett Perkins |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/5/2/261 |
Similar Items
-
Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs
by: Masakiyo Hosokawa
Published: (2008-02-01) -
Recent Development of Prodrugs of Gemcitabine
by: Bhoomika Pandit, et al.
Published: (2022-03-01) -
A Pharmacokinetic and Pharmacodynamic Evaluation of the Anti-Hepatocellular Carcinoma Compound 4-<i>N</i>-Carbobenzoxy-gemcitabine (Cbz-dFdC)
by: Yilin Sun, et al.
Published: (2020-05-01) -
Involvement of Carboxylesterase in Hydrolysis of Propranolol Prodrug during Permeation across Rat Skin
by: Harunobu Iwase, et al.
Published: (2013-07-01) -
The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs
by: Yasuhiro Tsume, et al.
Published: (2014-01-01)